60% of high-priority research goes unfunded.
Grading childhood brain and spinal cord tumours
The grade is a description of how the cancer cells look compared to normal cells. To find out the grade of a childhood brain or spinal cord tumour, the pathologist looks at a tissue sample from the tumour under a microscope. The pathologist gives a brain or spinal cord tumour a grade from I to IV based on the grading system developed by the World Health Organization (WHO). The lower the number, the lower the grade.
Brain and spinal cord tumours may contain several grades of cells. The grade of the tumour is determined by the highest grade of cells found even if most of the tumour cells are a lower grade.
How different the cancer cells are is described as differentiation.
Low grade means that the cancer cells are well differentiated. They look almost like normal cells. Lower grade cancer cells tend to be slow growing and are less likely to spread. Grade I and grade II brain and spinal cord tumours are low grade and are often called benign tumours.
High grade means that the cancer cells are poorly differentiated or undifferentiated. They look less normal, or more abnormal. Higher grade cancer cells tend to grow more quickly and are more likely to spread than low-grade cancer cells. Grade III and grade IV brain and spinal cord tumours are high grade and are called malignant tumours.
Tumours do not always stay the same. If a tumour changes, the name and grade of the tumour might change. A low-grade tumour might become high grade or might come back (recur) as a high-grade tumour.
Knowing the grade gives your healthcare team an idea of how quickly the cancer may be growing and how likely it is to spread. This helps them plan your treatment. The grade can also help the healthcare team predict future outcomes (your prognosis) and how the cancer might respond to treatment.
Volunteering during Daffodil Month is an incredibly rewarding experience, whether you have been touched by cancer or not.
Great progress has been made
Some cancers, such as thyroid and testicular, have survival rates of over 90%. Other cancers, such as pancreatic, brain and esophageal, continue to have very low survival rates.